Recent articles
Wall Street's 2 Favorite Cannabis Stocks May Surprise You
These two laggards are Wall Street's top picks in the rapidly emerging cannabis industry.
3 Top Healthcare Stocks to Buy Right Now
These three healthcare stocks could be outstanding additions to your portfolio.
Better Buy: OrganiGram Holdings vs. Walgreens Boots Alliance
Which of these healthcare stocks is the better buy right now?
Why Array BioPharma Stock Is on Fire Today
Pfizer moves to acquire the cancer specialist in a deal valued at $11.4 billion.
3 Top Diabetes Stocks to Watch in June
These three diabetes stocks have a lot going on this month.
3 Top Marijuana Stocks to Watch in June
With the industry possibly cooling off, here are the names to remember.
Better Buy: Biogen vs. Amgen
Which of these elite biotechs is the better buy right now?
Is Aphria a Buy?
Aphria is the cheapest pot producer in all of Canada by a wide margin.
2 Ultra-High-Growth Biotech Stocks to Buy Now
Amicus Therapeutics and Array BioPharma are two top growth stocks to consider buying now.
Why Sorrento Therapeutics Is Getting Crushed Today
The biopharma stock is continuing to experience volatility today.
Cronos Group Could Be the Bargain of a Lifetime
Wall Street may be vastly underestimating Cronos' long-term value proposition.
3 Top Biotech Stocks to Buy Right Now
These three biotech stocks should turn out to be outstanding long-term growth vehicles.
Better Buy: Johnson & Johnson vs. GlaxoSmithKline
Which of these top dividend-paying pharma stocks is the better buy right now?
Better Turnaround Play: Bausch Health Companies or Teva Pharmaceutical Industries
Which of these fallen stars has the more compelling comeback story?
Better Buy: AbbVie vs. Pfizer
AbbVie and Pfizer are both undergoing a radical makeover. Which company should investors trust to come out even stronger?
3 Top Healthcare Stocks to Buy Right Now
These stocks are bargains.
Did Geron's Big Announcement Just Go Unnoticed?
Geron hints at a way forward for imetelstat in myelofibrosis, but the market isn't buying it.
Why MacroGenics, Inc. Stock Is Heating Up Today
MacroGenics shares jumped in response to another major clinical update today.
Are These 2 Beaten-Down Biotech Stocks Worth the Risk?
Catalyst Pharmaceuticals and Novavax have had tough go of it in May. Could better days be close at hand?
Is Tilray Finally a Buy?
Is Tilray's strong first-quarter report a good reason to buy this flagging pot stock?